A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib
Clinical trial NCT01215487 · COMPLETED
Trial details
- NCT number
- NCT01215487
- Sponsor
- University of British Columbia
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-10-01
- Primary completion
- 2020-05-31
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.